PlainRecalls
FDA Devices Moderate Class II Terminated

DiaSorin, PRO-Trac II Tacrolimus ELISA kit, REF 32400 and 32400-CN. Product Usage: The PRO-Trac II Tacrolimus ELISA kit is an in vitro reagent system intended for the quantitative determination of tacrolimus (Prografl, FK506) and some metabolites in human EDT A or heparinized whole blood as an aid in the management of liver transplant patients receiving tacrolimus therapy.

Reported: April 29, 2015 Initiated: March 16, 2015 #Z-1464-2015

Product Description

DiaSorin, PRO-Trac II Tacrolimus ELISA kit, REF 32400 and 32400-CN. Product Usage: The PRO-Trac II Tacrolimus ELISA kit is an in vitro reagent system intended for the quantitative determination of tacrolimus (Prografl, FK506) and some metabolites in human EDT A or heparinized whole blood as an aid in the management of liver transplant patients receiving tacrolimus therapy.

Reason for Recall

Instability in the PRO-Trac II Tacrolimus ELISA kit which may cause falsely elevated patient results.

Details

Recalling Firm
Diasorin Inc.
Units Affected
451 kits
Distribution
Worldwide Distribution - US in the state of CA and the countries of: CHINA, BELGIUM, ARGENTINA, and INDIA.
Location
Stillwater, MN

Frequently Asked Questions

What product was recalled?
DiaSorin, PRO-Trac II Tacrolimus ELISA kit, REF 32400 and 32400-CN. Product Usage: The PRO-Trac II Tacrolimus ELISA kit is an in vitro reagent system intended for the quantitative determination of tacrolimus (Prografl, FK506) and some metabolites in human EDT A or heparinized whole blood as an aid in the management of liver transplant patients receiving tacrolimus therapy.. Recalled by Diasorin Inc.. Units affected: 451 kits.
Why was this product recalled?
Instability in the PRO-Trac II Tacrolimus ELISA kit which may cause falsely elevated patient results.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 29, 2015. Severity: Moderate. Recall number: Z-1464-2015.